Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Falk W Lohoff

Showing results (21-30 of 134) with videos related to

Pageof 14
Sort By:
Addiction Biology|February 4, 2021
Epigenetics of alcohol use disorder-A review of recent advances in DNA methylation profilingMartha J Longley, Jisoo Lee, Jeesun Jung, et al.
Psychiatry Research|August 27, 2013
Genetic polymorphisms in the PACAP and PAC1 receptor genes and treatment response to venlafaxine XR in generalized anxiety disorderAlissa J Cooper, Sneha Narasimhan, Karl Rickels, et al.
Pharmacology & Therapeutics|November 14, 2025
Treatment approaches for alcohol use disorder with metabolic dysfunctionAlexandra C Wagner, Jeesun Jung, Pal Pacher, et al.
Addiction (Abingdon, England)|May 11, 2018
Imaging resilience and recovery in alcohol dependenceKatrin Charlet, Annika Rosenthal, Falk W Lohoff, et al.
Journal of Clinical Medicine|April 30, 2021
PCSK9 and the Gut-Liver-Brain Axis: A Novel Therapeutic Target for Immune Regulation in Alcohol Use DisorderJi Soo Lee, Emma M O'Connell, Pal Pacher, et al.
Neuroimage|November 26, 2013
Individual differences in the morphometry and activation of time perception networks are influenced by dopamine genotypeMartin Wiener, Yune-Sang Lee, Falk W Lohoff, et al.
Neuroscience Letters|April 8, 2018
Random forest based classification of alcohol dependence patients and healthy controls using resting state MRIXi Zhu, Xiaofei Du, Mike Kerich, et al.
Expert Opinion on Pharmacotherapy|September 29, 2011
Pharmacological treatment of generalized anxiety disorderJennifer A Reinhold, Laura A Mandos, Karl Rickels, et al.
Expert Opinion on Pharmacotherapy|September 14, 2012
Evidence for the use of vilazodone in the treatment of major depressive disorderJennifer A Reinhold, Laura A Mandos, Falk W Lohoff, et al.
Neuroscience and Biobehavioral Reviews|April 5, 2023
Proprotein convertase subtilisin/kexin type 9 (PCSK9) in the central nervous systemAndrew S Bell, Josephin Wagner, Daniel B Rosoff, et al.
Pageof 14

Showing results (21-30 of 134) with videos related to

Sort By:
Pageof 14
Addiction Biology|February 4, 2021
Epigenetics of alcohol use disorder-A review of recent advances in DNA methylation profilingMartha J Longley, Jisoo Lee, Jeesun Jung, et al.
Psychiatry Research|August 27, 2013
Genetic polymorphisms in the PACAP and PAC1 receptor genes and treatment response to venlafaxine XR in generalized anxiety disorderAlissa J Cooper, Sneha Narasimhan, Karl Rickels, et al.
Pharmacology & Therapeutics|November 14, 2025
Treatment approaches for alcohol use disorder with metabolic dysfunctionAlexandra C Wagner, Jeesun Jung, Pal Pacher, et al.
Addiction (Abingdon, England)|May 11, 2018
Imaging resilience and recovery in alcohol dependenceKatrin Charlet, Annika Rosenthal, Falk W Lohoff, et al.
Journal of Clinical Medicine|April 30, 2021
PCSK9 and the Gut-Liver-Brain Axis: A Novel Therapeutic Target for Immune Regulation in Alcohol Use DisorderJi Soo Lee, Emma M O'Connell, Pal Pacher, et al.
Neuroimage|November 26, 2013
Individual differences in the morphometry and activation of time perception networks are influenced by dopamine genotypeMartin Wiener, Yune-Sang Lee, Falk W Lohoff, et al.
Neuroscience Letters|April 8, 2018
Random forest based classification of alcohol dependence patients and healthy controls using resting state MRIXi Zhu, Xiaofei Du, Mike Kerich, et al.
Expert Opinion on Pharmacotherapy|September 29, 2011
Pharmacological treatment of generalized anxiety disorderJennifer A Reinhold, Laura A Mandos, Karl Rickels, et al.
Expert Opinion on Pharmacotherapy|September 14, 2012
Evidence for the use of vilazodone in the treatment of major depressive disorderJennifer A Reinhold, Laura A Mandos, Falk W Lohoff, et al.
Neuroscience and Biobehavioral Reviews|April 5, 2023
Proprotein convertase subtilisin/kexin type 9 (PCSK9) in the central nervous systemAndrew S Bell, Josephin Wagner, Daniel B Rosoff, et al.
Pageof 14